Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy

doi:10.12998/wjcc.v11.i27.6398

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2297)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

127

WORD

HTML

1085

Figures (1-3)

247

Tables (1-2)

250

Sum=1728

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

132

Download

338

Sum=470

Sep 26, 2023 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 26, 2023; 11(27): 6398-6406
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6398

Full Size Figure Download Figure

Figure 1 Algorithm of patient selection with strong hormone receptor-positive/ human epidermal grow factor 2-negative breast cancer. HR: Hormone receptor; HER2: Human epidermal grow factor 2.

Citation: Choi HJ, Lee JH, Jung CS, Ryu JM, Chae BJ, Lee SK, Yu JH, Kim SW, Nam SJ, Lee JE, Jung YJ, Kim HY. Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy. World J Clin Cases 2023; 11(27): 6398-6406
URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6398.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6398